These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 3072529
1. [Bone marrow transplant in acute leukemia in children. Experience of the Pesaro group]. Giardini C, Polchi P, Lucarelli G, Galimberti M, Moretti L. Pediatr Med Chir; 1988; 10(6):563-7. PubMed ID: 3072529 [Abstract] [Full Text] [Related]
5. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR. Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074 [Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Matsuyama T, Kojima S, Kato K. Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791 [Abstract] [Full Text] [Related]
7. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P. Cancer J Sci Am; 1996 Jul; 2(6):330-4. PubMed ID: 9166553 [Abstract] [Full Text] [Related]
8. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G. Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095 [Abstract] [Full Text] [Related]
10. Is veno-occlusive disease incidence influenced by the total-body irradiation technique? Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A. Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791 [Abstract] [Full Text] [Related]
19. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation. De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J. Bone Marrow Transplant; 1993 Oct; 12 Suppl 3():S2-6. PubMed ID: 8124252 [Abstract] [Full Text] [Related]
20. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]